UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Heerfordt's Syndrome Associated with Trigeminal Nerve Palsy and Reversed Halo Sign

Internal Medicine, 2021/06/01, Vol.60(11), pp.1747-1752

2021

Volltextzugriff (PDF)

Retrobulbar Optic Neuritis Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma

Internal Medicine, 2021/12/15, Vol.60(24), pp.3941-3945

2021

Volltextzugriff (PDF)

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers

Cancer science, 2021-05, Vol.112 (5), p.1853-1864

2021

Volltextzugriff (PDF)

Rapid and Long-term Response of Pulmonary Pleomorphic Carcinoma to Nivolumab

Internal Medicine, 2019/04/01, Vol.58(7), pp.985-989

2019

Volltextzugriff (PDF)

Severe Cytokine Release Syndrome and Immune Effector Cell-associated Neurotoxicity Syndrome in a Man Receiving Immune Checkpoint Inhibitors for Lung Cancer

Internal Medicine, 2024/05/01, Vol.63(9), pp.1261-1267

2024

Volltextzugriff (PDF)

Successful Re-administration of Osimertinib in Osimertinib-induced Interstitial Lung Disease with an Organizing Pneumonia Pattern: A Case Report and Literature Review

Internal Medicine, 2020/03/15, Vol.59(6), pp.823-828

2020

Volltextzugriff (PDF)

Dramatic Response of Brain Metastasis from EGFR-mutation-positive NSCLC to Dacomitinib

Internal Medicine, 2020/07/15, Vol.59(14), pp.1739-1740

2020

Volltextzugriff (PDF)

A Long-term Response to Nivolumab in a Case of PD-L1-negative Lung Adenocarcinoma with an EGFR Mutation and Surrounding PD-L1-positive Tumor-associated Macrophages

Internal Medicine, 2019/10/15, Vol.58(20), pp.3033-3037

2019

Volltextzugriff (PDF)

Successful Desensitization Treatment with Osimertinib after the Development of Osimertinib-induced Urticaria in a Patient Undergoing Treatment for Non-small Cell Lung Cancer Harboring the EGFR T790M Mutation

Internal Medicine, 2020/09/01, Vol.59(17), pp.2161-2164

2020

Volltextzugriff (PDF)

Anaplastic Lymphoma Kinase Fusion: A Review of Therapeutic Drugs and Treatment Strategies

Acta medica Okayama, 2020-10, Vol.74 (5), p.371-379

2020

Volltextzugriff (PDF)

Chemoradiotherapy for locally advanced lung cancer patients with interstitial lung abnormalities

Japanese journal of clinical oncology, 2019-05, Vol.49 (5), p.458-464

2019

Volltextzugriff (PDF)

Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK ‐rearranged non‐small cell lung cancer

Cancer science, 2023-11, Vol.114 (11), p.4343-4354

2023

Volltextzugriff (PDF)

Two Cases of Cytomegalovirus Colitis During the Treatment of Immune Checkpoint Inhibitor-Associated Colitis

Curēus (Palo Alto, CA), 2024-06

2024

Volltextzugriff (PDF)

Dasatinib-induced massive left chylothorax in a patient with chronic myeloid leukemia

Respiratory medicine case reports, 2022-01, Vol.37, p.101662, Article 101662

2022

Volltextzugriff (PDF)

MET or NRAS amplification is an acquired resistance mechanism to the third-generation EGFR inhibitor naquotinib

Scientific reports, 2018-01, Vol.8 (1), p.1955-11, Article 1955

2018

Volltextzugriff (PDF)

Beneficial effect of erlotinib and trastuzumab emtansine combination in lung tumors harboring EGFR mutations

Biochemical and biophysical research communications, 2020-11, Vol.532 (3), p.341-346

2020

Volltextzugriff (PDF)

A Prompt Diagnosis and Treatment of a Case of Nuclear Protein of the Testis Carcinoma Characterized by a Bronchial Lesion and High Serum Alpha-fetoprotein Level Following Genomic Testing

Internal Medicine, 2024, pp.2938-23

2024

Volltextzugriff (PDF)

First and repeat rebiopsy for detecting EGFR T790M mutation in non-small-cell lung cancer: CS-Lung-003 prospective observational registry study

Journal of cancer research and clinical oncology, 2022-08, Vol.148 (8), p.1869-1877

2022

Volltextzugriff (PDF)

Identification of targetable kinases in idiopathic pulmonary fibrosis

Respiratory research, 2022-02, Vol.23 (1), p.20-20, Article 20

2022

Volltextzugriff (PDF)

Recent trends in the treatment of unresectable stage III non-small-cell lung cancer

Respiratory investigation, 2019-07, Vol.57 (4), p.330-336

2019

Volltextzugriff (PDF)

A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R

Japanese journal of clinical oncology, 2021-05, Vol.51 (6), p.956-965

2021

Volltextzugriff (PDF)

EGFR-TKI acquired resistance in lung cancers harboring EGFR mutations in immunocompetent C57BL/6J mice

Lung cancer (Amsterdam, Netherlands), 2019-10, Vol.136, p.86-93

2019

Volltextzugriff (PDF)

Limited effect of afatinib in a non‐small cell lung cancer patient harboring an epidermal growth factor receptor K860I missense mutation: A case report

Thoracic cancer, 2021-06, Vol.12 (11), p.1770-1774

2021

Volltextzugriff (PDF)

Beneficial Effect of Osimertinib Readministration in Non-small-cell Lung Cancer Harboring an EGFR Mutation With a History of Acquired Resistance to Osimertinib

Internal Medicine, 2019, pp.2152-18

2019

Volltextzugriff (PDF)

Combined effect of cabozantinib and gefitinib in crizotinib‐resistant lung tumors harboring ROS 1 fusions

Cancer science, 2018-10, Vol.109 (10), p.3149-3158

2018

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(75)

Publikationsform

Artikel
(77)

Sprache

Englisch
(74)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(49)
Oncology
(23)
Humans
(22)
Lung Cancer
(21)
Case Report
(20)
Lung Neoplasms - Drug Therapy
(15)
Respiratory System
(15)
Female
(14)
Mutation
(14)
Epidermal Growth Factor
(11)
General & Internal Medicine
(10)
Medicine, General & Internal
(10)
Non-Small Cell Lung Carcinoma
(10)
Aged
(9)
Epidermal Growth Factor Receptors
(9)
Osimertinib
(9)
Tumors
(9)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(8)
Case Reports
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Heerfordt's Syndrome Associated with Trigeminal Nerve Palsy and Reversed Halo Sign

Retrobulbar Optic Neuritis Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers

Rapid and Long-term Response of Pulmonary Pleomorphic Carcinoma to Nivolumab

Severe Cytokine Release Syndrome and Immune Effector Cell-associated Neurotoxicity Syndrome in a Man Receiving Immune Checkpoint Inhibitors for Lung Cancer

Successful Re-administration of Osimertinib in Osimertinib-induced Interstitial Lung Disease with an Organizing Pneumonia Pattern: A Case Report and Literature Review

Dramatic Response of Brain Metastasis from EGFR-mutation-positive NSCLC to Dacomitinib

A Long-term Response to Nivolumab in a Case of PD-L1-negative Lung Adenocarcinoma with an EGFR Mutation and Surrounding PD-L1-positive Tumor-associated Macrophages

Successful Desensitization Treatment with Osimertinib after the Development of Osimertinib-induced Urticaria in a Patient Undergoing Treatment for Non-small Cell Lung Cancer Harboring the EGFR T790M Mutation

Anaplastic Lymphoma Kinase Fusion: A Review of Therapeutic Drugs and Treatment Strategies

Chemoradiotherapy for locally advanced lung cancer patients with interstitial lung abnormalities

Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK ‐rearranged non‐small cell lung cancer

Two Cases of Cytomegalovirus Colitis During the Treatment of Immune Checkpoint Inhibitor-Associated Colitis

Dasatinib-induced massive left chylothorax in a patient with chronic myeloid leukemia

MET or NRAS amplification is an acquired resistance mechanism to the third-generation EGFR inhibitor naquotinib

Beneficial effect of erlotinib and trastuzumab emtansine combination in lung tumors harboring EGFR mutations

A Prompt Diagnosis and Treatment of a Case of Nuclear Protein of the Testis Carcinoma Characterized by a Bronchial Lesion and High Serum Alpha-fetoprotein Level Following Genomic Testing

First and repeat rebiopsy for detecting EGFR T790M mutation in non-small-cell lung cancer: CS-Lung-003 prospective observational registry study

Identification of targetable kinases in idiopathic pulmonary fibrosis

Recent trends in the treatment of unresectable stage III non-small-cell lung cancer

A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R

EGFR-TKI acquired resistance in lung cancers harboring EGFR mutations in immunocompetent C57BL/6J mice

Limited effect of afatinib in a non‐small cell lung cancer patient harboring an epidermal growth factor receptor K860I missense mutation: A case report

Beneficial Effect of Osimertinib Readministration in Non-small-cell Lung Cancer Harboring an EGFR Mutation With a History of Acquired Resistance to Osimertinib

Combined effect of cabozantinib and gefitinib in crizotinib‐resistant lung tumors harboring ROS 1 fusions

Aktive Filter

Suchergebnisse filtern